Navigation Links
Inverness Medical Innovations Proposes to Acquire Concateno plc
Date:6/5/2009

WALTHAM, Mass., June 5 /PRNewswire-FirstCall/ -- Inverness Medical Innovations (NYSE: IMA) and Concateno plc today announced that they have reached agreement on a proposal for Inverness to acquire all of Concateno's outstanding share capital. Concateno, located in London, England, is a leading European supplier of drugs of abuse testing products and services with 2008 revenues of approximately 47.5 million pounds Sterling (or approximately $76 million). Concateno is quoted on the AIM market of the London Stock Exchange.

The acquisition is expected to be implemented by way of a court-approved scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006. The scheme of arrangement is subject to approval by the shareholders of Concateno and sanction of the High Court of Justice in England and Wales as well as other customary conditions. If approved the acquisition would be expected to become effective during the third quarter of 2009.

Under the proposed terms of the acquisition, each holder of Concateno shares will receive, for each Concateno share, 79 pence in cash and 0.02 shares of Inverness' common stock, based on Inverness' closing price per common share on the New York Stock Exchange on June 4, 2009 of $34.00 and applying an exchange rate of 1.00 pound:$1.61, for a total implied value per Concateno share of 121.24 pence. Based on information supplied by Concateno, there are approximately 103.2 million Concateno shares currently issued and outstanding after consideration of certain shares which will be repurchased by Concateno for nominal consideration and cancelled as a result of the transaction.

In the event that, as a result of changes in Inverness' stock price and exchange rates, the value of the total consideration payable per Concateno share is less than 120 pence, Inverness will be oblig
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
2. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
3. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
4. Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes
5. Inverness Medical Innovations Announces First Quarter 2009 Results
6. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 27, 2009 to Discuss First Quarter 2009 Results
7. Inverness Medical Innovations to Participate at Goldman Sachs Leveraged Finance Healthcare Conference on April 8, 2009
8. Eli Y. Adashi, MD, MS, FACOG, Joins Inverness Medical Innovations Board of Directors
9. Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test
10. Inverness Medical Innovations to Pay April Series B Dividend in Additional Shares of Series B Stock
11. Inverness Medical Innovations Agrees to Acquire Second Territory Rapid Diagnostics Business of ACON
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... News) -- Animals make great companions for senior citizens, but ... car are far more likely to crash than those who ... new study included 2,000 licensed drivers aged 70 and older. ... often they drove with their pet in the car. ... risk was twice as high as among those who never ...
(Date:5/25/2013)... 2013 Studies from Johns Hopkins University ... excessive weight and their inability to get adequate sleep. ... weight can naturally relieve many symptoms. , Johns ... sleep quality was significantly associated with overall weight loss, ... dated November 6th, 2012, researchers monitored 77 participants ...
(Date:5/25/2013)... On May 20, 2013 the Sydney ... to discuss or plan for their eventual demise, but it ... released a Must-Do List to help people properly arrange for ... a personal fact sheet.” , While not a formal document, ... personal data. It may include a summary of assets, ...
(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...
(Date:5/25/2013)... Many orthodontists have thought about moving their ... cloud is. Most people would naturally assume that ... their cloud service and support would own and maintain ... selling, they'd be wrong. Cloud providers lease space ... facility that houses servers and related equipment to run ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
... MADISON, N.J., Sept. 4 Quest Diagnostics Incorporated (NYSE: ... services, today announced that it was again selected to be part of ... and DJSI North America). The company is in its sixth year on ... American Index (since 2005). , , According to Sustainable ...
... strategies , FRIDAY, Sept. 4 (HealthDay News) -- ... United Kingdom and Australia rethink their efforts to combat ... healthy diets and exercise -- aren,t working. , In ... , Australian researchers followed more than 250 overweight and ...
... , WASHINGTON, Sept. 4 Nurses appear to be taking ... according to a survey released today by the Center for American Nurses ... The Nurse Investor Education Survey reveals that nurses may be ... needs. In fact, most nurses say they do not know what those ...
... , , NEW HAVEN, Conn., Sept. 4 ... discovery, development and commercialization of novel antibiotics for the treatment ... Kassberg has joined the company as Chief Business Officer. In ... development activities. , , Mr. Kassberg, age ...
... NEW YORK, Sept. 4 Delcath Systems, Inc. (Nasdaq: ... proprietary treatment method for primary and metastatic cancers to the ... Surgery for the University of Pittsburgh School of Medicine will ... Third Annual Conference on Saturday, September 5, 2009 in Milan, ...
... ... end-to-end payment solutions for merchants across all distribution channels, and ClaimLogic, a leader ... a partnership today that enables ClaimLogic to provide PCI-compliant credit card processing services ... ...
Cached Medicine News:Health News:Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index 2Health News:Nurses and Retirement Security: A Looming Crisis? 2Health News:Nurses and Retirement Security: A Looming Crisis? 3Health News:Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer 2Health News:Delcath Systems, Inc. to Present Poster at International Liver Cancer Association 2009 Annual Conference 2Health News:EPX and ClaimLogic Announce Credit Card Processing Partnership 2Health News:EPX and ClaimLogic Announce Credit Card Processing Partnership 3
(Date:5/24/2013)... NEW YORK , May 24, 2013 In ... Takeover Rules and Rule 14e-1 of the United States Exchange ... levels its original offer for Elan Corporation (NYSE: ELN). ... Acquisition Limited ("Royalty Pharma") made an offer for the entire ... Elan Corporation, plc ("Elan") (the "Original Offer").  ...
(Date:5/24/2013)... and BOSTON , May 24, 2013 ... and development company, is pleased to announce that it has engaged ... augment the Company,s business development capabilities in Japan ... than 15 years of experience in business development, licensing and alliance ... Inc., Roche Pharma ( Japan ), Nippon Roche and ...
(Date:5/23/2013)... PARÍS, 24 de mayo de 2013  Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... and SAN DIEGO, Nov. 12 Tobira Therapeutics, ... and product discovery for the treatment of life-threatening ... and results from two double-blind, placebo-controlled studies of ... studies, a single-ascending dose (SAD) study and the ...
... , BOTHELL, Wash., Nov. 11 ... ), a global leader in automated external defibrillator ( ... appointed Peter Kingma as senior vice president, effective immediately. ... Marver, president and chief executive officer, and oversees the ...
Cached Medicine Technology:Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference 2Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 2Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 3Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 4Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: